More recently, Xu et al. [54] analyzed TCGA CRC CNV, DNA methylation and gene expression data to identify LRRC26 and REP15 as prognostic CRC driver events in which high LRRC26 and REP15 expression was inversely correlated with the presence of metastases and tumor stage. The gene discussed is REP15; the disease is neoplasm.